Do drugs or bugs cause GERD?

Journal of Clinical Gastroenterology

Volumn 41, Issue SUPPL.2, 2007, Pages

  McCarthy, Denis M ^a,b  

^a VA Medical Center   (United States)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

Bacteria; GERD; Helicobacter; Hiatus hernia; LES; NSAIDs

Indexed keywords

ACETYLSALICYLIC ACID; ALENDRONIC ACID; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALPRENOLOL; ANTIHISTAMINIC AGENT; ASCORBIC ACID; BENZODIAZEPINE; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLINDAMYCIN; DOPAMINE; DOXYCYCLINE; ESTRAMUSTINE PHOSPHATE; IRON SALT; ISOTRETINOIN; LIDOCAINE; LINCOMYCIN; NARCOTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLIN G; POTASSIUM CHLORIDE; QUINIDINE GLUCONATE; RISEDRONIC ACID; TETRACYCLINE; THEOPHYLLINE; TINIDAZOLE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VALPROIC ACID;

CONFERENCE PAPER; DISEASE ASSOCIATION; DRUG EFFECT; ESOPHAGITIS; ESOPHAGUS FUNCTION; GASTROESOPHAGEAL REFLUX; HELICOBACTER PYLORI; HUMAN; LOWER ESOPHAGUS SPHINCTER PRESSURE; PRIORITY JOURNAL; SIDE EFFECT;

EID: 34250781709     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCG.0b013e31803238fb     Document Type: Conference Paper

References (32)

1. Hey H, Sorensen K, Jorgensen FB, et al. Esophageal transit of six commonly used tablets and capsules. BMJ. 1982;285:1717-1719.
2. Kikendall JW. Pill esophagitis. J Clin Gastroenterol. 1999;28:298-305.
3. Bott SJ, McCallum RW. Medicine induced esophageal injury: survey of the literature. Med-Toxicol. 1986;1:449-456.
4. Ouatu-Lascar R. Esophageal mucosal diseases in the elderly. Drugs Aging. 1998;12:261-276.
5. Grande L, Lacima G, Ross E, et al. Determination of esophageal motility with age: a manometric study of 79 healthy subjects. Am J Gastroenterol. 1999;94:1795-1801.
6. Achem AC, Achem SR, Stark ME, et al. Failure of esophageal peristalsis in older patients: association with esophageal acid exposure. Am J Gastroenterol. 2003;98:35-39.
7. Wu JH, Chang CS, Chen GH, et al. Felodipine does not increase reflux episodes in patients with GERD. Hepato-Gastroenterology. 2000;47:1328-1331.
8. Jenkinson LR, Norris TL, Watson A. Gastroesophageal disease associated with nifedipine. Aliment Pharmacol Ther. 1988;2:337-339.
9. Vaughan TL, Farrow DC, Hansten PD, et al. Risk of esophageal and gastric adenocarcinoma in relation to the use of calcium channel blockers, asthma drugs and other medications that promote gastroesophageal reflux. Cancer Epidemiol Biomarkers Prev. 1998;7:749-756.
10. Lagergren J, Bergstrom R, Adami H, et al. Associations between medications that relax the lower esophageal sphincter and risk for esophageal adenocarcinoma. Ann Int Med. 2000;133:165-175.
11. Corley DA, Levin TR, Habel LA, et al. Barrett's esophagus and medications that relax the lower esophageal sphincter. Am J Gastroenterol. 2006;101:937-944.
12. Morgan GP, Williams JG. Inflammatory mediators in the esophagus. Gut. 1995;35:297-298.
13. El Serag H, Sonnenberg A. Non-steroidal drugs and esophageal disorders. In: Bianchi Porro G, Pace F, eds. Argomentin Di Patologia Esofogea a Cura. Vol 4. Bologna, Italy: Springer-Verlag; 1999:55-62.
14. Taha AS, Dahill I, Lee FD, et al. Oesophageal histology in long-term users of non-steroidal anti-inflammatory drugs. J Clin Pathol. 1994;47:705-708.
15. Heller SR, Fellows IW, Ogilvie AL, et al. Non-steroidal anti-inflammatory drugs and benign oesophageal stricture. BMJ. 1982;285:167-168.
16. Shallcross TM, Wyatt TI, Rathbone BJ, et al. Non-steroidal antiinflammatory drugs and Helicobacter pylori in patients with oesophageal ulceration. Br J Rheumatol. 1990;29:288-290.
17. Lanas A, Hirschowitz BJ. Significant role of aspirin use in patients with esophagitis. J Clin Gastroenterol. 1991;13:622-627.
18. El Serag H, Sonnenberg A. Association of esophagitis and esophageal strictures with diseases treated with non-steroidal anti-inflammatory drugs. Am J Gastroenterol. 1997;92:52-56.
19. Avidan B, Sonnenberg A, Schnell TG, et al. Risk factors for erosive reflux esophagitis: a case-control study. Am J Gastroenterol. 2001;96:41-46.
20. Avidan B, Sonnenberg A, Schnell TG, et al. Risk factors of esophagitis in arthritic patients. Eur J Gastroenterol Hepatol. 2001;13:1095-1099.
21. Faigel DO, Metz DC. Prevalence, etiology and prognostic significance of upper gastrointestinal hemorrhage in diabetic ketoacidosis. Dig Dis Sci. 1996;41:1-8.
22. Augusto F, Fernandes V, Cremers MI, et al. Acute necrotizing esophagitis: a large retrospective case series. Endoscopy. 2004;36:411-415.
23. Yasuda H, Yamada M, Endo Y, et al. Acute necrotizing esophagitis: role of non-steroidal anti-inflammatory drugs. J Gastroenterol. 2006;41:193-197.
24. McColl KEL. Helicobacter pylori and gastro-oesophageal reflux disease: the European perspective. Aliment Pharmacol Therap. 2004;20(suppl 8):36-39.
25. Delaney B, McColl K. Helicobacter pylori and gastro-oesophageal disease. Aliment Pharmacol Ther. 2005;22(suppl 1):32-40.
26. Vakil N, Talley NJ, Stolte M, et al. Patterns of gastritis and the effect of eradicating Helicobacter pylori on gastroesophageal reflux disease in western patients with non-ulcer dyspepsia. Aliment Pharmacol Ther. 2006;24:55-63.
27. El-Omar EM, Oien K, El-Nujumi A, et al. Helicobacter pylori infection and chronic gastric acid hyposecretion. Gastroenterology. 1997;113:15-24.
28. Labenz J, Blum AL, Bayerdorffer E, et al. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology. 1997;112:1442-1446.
29. Gillen D, Wirz AA, McColl KEL, et al. Helicobacter eradication releases prolonged increased acid secretion following omeprazole therapy. Gastroenterology. 2004;126:980-988.
30. Martinek J, Pantoflickova DB, Hucl TA, et al. Absence of Nocturnal acid breakthrough in Helicobacter positive patients treated with twice daily omeprazole. Eur J Gastroenterol Hepatol. 2004;16:445-450.
31. Nasser NN, Gregg CR. Esophageal infections. Curr Treatment Options Gastroenterol. 1998;1:56-63.
32. Del Valle L, White MK, Enam S, et al. Detection of JC virus DNA sequences and expression of viral T-antigen and agnoprotein in esophageal carcinoma. Cancer. 2005;103:516-527.